spacer
home > ebr > autumn 2018 > goal!
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

 
News and Press Releases

Juvisé Pharmaceuticals Successfully Complete a €400M Refinancing Following the Acquisition of the Worldwide Rights of Pylera

Paris, France, July 5, 2022: The French speciality pharmaceutical company, Juvisé Pharmaceuticals has recently completed a transaction with AbbVie, regarding the acquisition of the worldwide commercial rights of Pylera®. Details of this transaction remain undisclosed.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement